## 1-Phenyl-3-trifluoromethyl-5-hydroxypyrazole: A Promising Scaffold for Drug Discovery
**1-Phenyl-3-trifluoromethyl-5-hydroxypyrazole** is a heterocyclic compound with a specific structure that has attracted significant attention in medicinal chemistry research.
**Key features of the molecule:**
* **Pyrazole ring:** This five-membered ring with two nitrogen atoms is a common structural motif in pharmaceuticals and agrochemicals.
* **Phenyl substituent:** The phenyl group adds to the molecule's lipophilicity and can interact with hydrophobic pockets on protein targets.
* **Trifluoromethyl group:** This group is known for its electron-withdrawing properties, which can influence the molecule's reactivity and biological activity.
* **Hydroxyl group:** This group can participate in hydrogen bonding interactions and is often involved in modulating the compound's acidity and solubility.
**Why is it important for research?**
This specific pyrazole derivative has shown promising biological activity in various research areas, including:
* **Anti-cancer agents:** Studies have shown that 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole derivatives can exhibit significant anti-proliferative activity against various cancer cell lines. This suggests potential for developing novel anticancer drugs.
* **Anti-inflammatory agents:** The compound has also been found to possess anti-inflammatory properties, potentially due to its ability to modulate specific signaling pathways involved in inflammation.
* **Antimicrobial agents:** Some derivatives of this molecule have demonstrated antibacterial and antifungal activity, making them potential leads for developing new antibiotics and antifungals.
**Further Research Potential:**
The unique structural features of 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole make it a versatile scaffold for further research and development. Scientists can modify the molecule by adding different substituents to the pyrazole ring, the phenyl group, or the hydroxyl group. This allows for the exploration of a broad range of potential therapeutic applications.
**Overall, 1-phenyl-3-trifluoromethyl-5-hydroxypyrazole represents a promising lead for the discovery and development of new pharmaceuticals with diverse biological activities.** The research into this compound continues to grow, highlighting its importance in the field of medicinal chemistry.
1-phenyl-3-trifluoromethyl-5-hydroxypyrazole: metabolite of flupyrazofos [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 892717 |
SCHEMBL ID | 537395 |
SCHEMBL ID | 486072 |
MeSH ID | M0300460 |
Synonym |
---|
HMS1590E01 |
96145-98-1 |
2-phenyl-5-trifluoromethyl-2h-pyrazol-3-ol |
STK312844 |
1-phenyl-3-(trifluoromethyl)-1h-pyrazol-5-ol |
SR-01000636391-1 |
MAYBRIDGE1_004315 |
AKOS000310728 |
HMS553M05 |
2-phenyl-5-(trifluoromethyl)-1h-pyrazol-3-one |
5-hydroxy-1-phenyl-3-(trifluoromethyl)-1h-pyrazole |
5-hydroxy-1-phenyl-3-trifluoromethylpyrazole |
CCG-46714 |
2-phenyl-5-(trifluoromethyl)pyrazol-3-ol |
FT-0649241 |
1-phenyl-3-trifluoromethyl-5-pyrazolone |
SCHEMBL537395 |
1-phenyl-3-trifluoromethyl-5-hydroxypyrazole |
1-phenyl-3-trifluoromethyl-1h-pyrazol-5-ol |
mfcd03714773 |
SCHEMBL486072 |
CS-10775 |
AC-26699 |
sr-01000253389 |
SR-01000253389-1 |
DTXSID60358397 |
2-phenyl-5-(trifluoromethyl)-1,2-dihydro-3h-pyrazol-3-one |
1-phenyl-3-trifluoromethylpyrazol-5-one |
1-phenyl-3-[trifluoromethyl]-1h-pyrazol-5-ol |
CS-0040063 |
1h-pyrazol-5-ol,1-phenyl-3-(trifluoromethyl)- |
1h-pyrazol-5-ol, 1-phenyl-3-(trifluoromethyl)- |
781-93-1 |
AMY11034 |
2-phenyl-5-(trifluoromethyl)-2,3-dihydro-1h-pyrazol-3-one |
BBL039000 |
EN300-229754 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.69) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |